NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BETANTITOPOINT-CCDSVX-CMIV1-26MAY20® povidone-iodine (poh-vi-dohn-ahy-uh-dahyn) Consumer Medicine Information WHAT IS IN THIS LEAFLET This
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MICARDIS CMI0045-17 Tablets telmisartan Consumer Medicine Information What is in this leaflet
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BREVINOR-1® 28 DAY Ethinylestradiol and Norethisterone Consumer Medicine Information What is in
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PROZAC® V3.0 fluoxetine hydrochloride Consumer Medicine Information What is in this leaflet
Read moreChildren and young people can experience a range of mental health issues specifically behavioral and emotional psychological conditions such as disruptive behavioral disorders (DBD). What
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DILART HCT Valsartan and hydrochlorothiazide CONSUMER MEDICINE INFORMATION What is in this
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OGIVRI® contains the active ingredient trastuzumab (rch) Consumer Medicine Information What is
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SYMDEKO® CMI 5 MARCH 19 This medicine is subject to additional monitoring.
Read moreSkip to: Diagnosis of pediatric migraine Laboratory tests and neuroimaging Management of pediatric migraine Acute treatment, chronic management, and pharmacotherapy Lifestyle modifications Pediatric migraine is
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SIFROL ER CMI0120-08 extended-release tablets pramipexole dihydrochloride monohydrate Consumer Medicine Information What
Read more